Efficiency and Safety

Application of VETERA-DDW-25 deuterium-depleted anticancer preparation enabled healing tumorous diseases routinely and free of side effects in veterinary medicine. VETERA-DDW-25 proved its extraordinary efficiency in a broad spectrum of tumors, so that this preparation provides a more efficient and also milder tool for treating malignant diseases in small animals than anything before.

Applied on malignant tumors in initial stage, a recovery rate of 70-80% can be achieved with VETERA-DDW-25. The product proved to be efficient in combination with surgery – in case of operable tumors – or as sole treatment. Application of the product can fully eliminate the need for operation; alternatively, the tumor brought to regression by previous application of VETERA-DDW-25 can be safely removed surgically.

Small animals treated with mammary tumors showed a response rate higher than 70%; in more than 50% of them, complete recovery was achieved. Similarly excellent effectiveness was observed in dogs and cats with rectal tumors, and more than 70% of cats with lymphoid leucosis showed complete recovery.

Long-term animal experiments and practical application have both shown that yearly cures of 1.5-2 months with the product can minimize the likelihood of cancer development, and substantially reduce the chance of relapse in those small animals made already tumor-free.

The veterinary anti-tumor preparation Vetera-DDW-25 with reduced deuterium content has been demonstrated to have no harmful health effects and no toxicity. In almost two decades of its application, no drug interaction has been observed, and since its authorization, the competent authority received no reports of adverse effects, undesired events or lack of efficacy.

Animals consume Vetera-DDW-25 willingly and tolerate the treatment well. Lassitude and drowsiness can appear during application, but these recede or disappear in 2-3 weeks.